Claire Rychlewski is an Editor at Axios Pro. She specializes in health and wellness, supply chain and logistics, and employee benefits, focusing on topics such as logistics technology, consumer health, and workplace health and safety. Claire's insights have been featured in Syncron, Axios, Industry Today Media, and MSN.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Claire Rychlewski's coverage focuses on business, tech, health, healthcare & pharmaceutical industries. She appears to prioritize articles that include press releases and private sector announcements. Her article titles mostly revolve around mergers and acquisitions in the healthcare industry.
If you are looking to pitch to Claire Rychlewski, consider offering insights into recent M&A activities or significant developments within the healthcare, medtech, or telehealth sectors. Additionally, providing data-backed analysis or exclusive access to notable industry figures could be appealing to her given her frequent citations of data in her articles.
Given that there is no specified geographic focus for Claire’s coverage attributes suggest she takes a broad view of these industries with interest in international as well as domestic market movements and trends.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Kardigan, a clinical-stage cardiac disease drugmaker, raised about $400 million in its IPO.
Demand for pharmacovigilance is rising as drugmakers manage larger safety datasets, increasingly complex medicines and tighter regulatory scrutiny.
AbbVie said Monday it agreed to acquire Apogee Therapeutics for $10.9 billion in cash.
ArisGlobal, a sponsor-backed AI drug development software company, has lost out on two prospective acquisitions.
Martis Capital is acquiring health comms agency Deerfield Group from Edgewater Partners for up to $280 million, Axios Pro has learned.
The big picture: Medical comms dealmaking is heating up as private equity gets behind pharma's rising dependence on outsourced marketing support.
The deal creates a specialty chemicals giant that's eyeing the fast-growing data-center cooling market.
The more politically responsive independent agencies become, the more sharply oversight will fluctuate.
The auction will test the strength of buyer demand in the pharma commercialization market.
Apollo Global Management agreed to buy a minority stake in Bayer's contraceptives business for $3.43 billion, the companies said Friday.
